X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare AANJANEYA LIFECARE with Elder Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs ELDER PHARMA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. DATSONS LABS ELDER PHARMA DR. DATSONS LABS/
ELDER PHARMA
 
P/E (TTM) x -10.9 -0.2 - View Chart
P/BV x 0.2 0.1 160.9% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 DR. DATSONS LABS   ELDER PHARMA
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
ELDER PHARMA
Jun-14
DR. DATSONS LABS/
ELDER PHARMA
5-Yr Chart
Click to enlarge
High Rs126380 33.1%   
Low Rs31188 16.4%   
Sales per share (Unadj.) Rs133.0491.2 27.1%  
Earnings per share (Unadj.) Rs0.2-3.2 -4.8%  
Cash flow per share (Unadj.) Rs6.614.4 45.9%  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs128.8376.5 34.2%  
Shares outstanding (eoy) m31.6620.54 154.1%   
Bonus/Rights/Conversions FCCB--  
Price / Sales ratio x0.60.6 101.8%   
Avg P/E ratio x516.1-89.3 -578.2%  
P/CF ratio (eoy) x11.819.7 60.1%  
Price / Book Value ratio x0.60.8 80.5%  
Dividend payout %00-   
Avg Mkt Cap Rs m2,4775,833 42.5%   
No. of employees `000NANA-   
Total wages/salary Rs m562,179 2.6%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m4,21110,089 41.7%  
Other income Rs m79257 30.7%   
Total revenues Rs m4,28910,346 41.5%   
Gross profit Rs m569-792 -71.8%  
Depreciation Rs m204361 56.6%   
Interest Rs m4302,756 15.6%   
Profit before tax Rs m13-3,653 -0.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m03,713 0.0%   
Tax Rs m6125 4.9%   
Profit after tax Rs m5-65 -7.3%  
Gross profit margin %13.5-7.8 -172.0%  
Effective tax rate %48.0-3.4 -1,402.0%   
Net profit margin %0.1-0.6 -17.6%  
BALANCE SHEET DATA
Current assets Rs m6,8529,240 74.2%   
Current liabilities Rs m6,7119,998 67.1%   
Net working cap to sales %3.3-7.5 -44.6%  
Current ratio x1.00.9 110.5%  
Inventory Days Days16146 347.3%  
Debtors Days Days31860 531.3%  
Net fixed assets Rs m3,67310,124 36.3%   
Share capital Rs m317206 153.9%   
"Free" reserves Rs m3,7615,582 67.4%   
Net worth Rs m4,0787,734 52.7%   
Long term debt Rs m1,6714,889 34.2%   
Total assets Rs m12,63322,882 55.2%  
Interest coverage x1.0-0.3 -316.5%   
Debt to equity ratio x0.40.6 64.8%  
Sales to assets ratio x0.30.4 75.6%   
Return on assets %3.411.8 29.3%  
Return on equity %0.1-0.8 -13.9%  
Return on capital %7.722.3 34.4%  
Exports to sales %22.93.0 753.4%   
Imports to sales %14.30.4 3,346.3%   
Exports (fob) Rs m964307 314.4%   
Imports (cif) Rs m60243 1,396.5%   
Fx inflow Rs m964307 314.4%   
Fx outflow Rs m607125 484.5%   
Net fx Rs m357181 196.9%   
CASH FLOW
From Operations Rs m1,34511,754 11.4%  
From Investments Rs m-2,256-561 402.4%  
From Financial Activity Rs m-1,200-6,762 17.7%  
Net Cashflow Rs m-2,1114,432 -47.6%  

Share Holding

Indian Promoters % 4.5 39.6 11.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 7.5 -  
FIIs % 1.4 16.8 8.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 94.1 36.1 260.7%  
Shareholders   20,807 16,479 126.3%  
Pledged promoter(s) holding % 0.0 77.6 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. DATSONS LABS With:   AUROBINDO PHARMA  MERCK LTD  SANOFI INDIA  FULFORD INDIA  ORCHID PHARMA LTD  

Compare DR. DATSONS LABS With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 190 Points Higher; Consumer Durable and Healthcare Stocks Witness Buying(Closing)

After trimming sharp losses in the afternoon session, Indian share markets continued to witness buying interest and ended the day on a positive note.

Related Views on News

Hindustan Aeronautics IPO: Yet Another Play on India's Defence Sector (IPO)

Mar 14, 2018

Should you apply for the IPO of state-run military aircraft maker Hindustan Aeronautics?

Bharat Dynamics IPO: Worth Betting on Defence Manufacturing? (IPO)

Mar 12, 2018

Should you apply for the IPO of Bharat Dynamics, India's first state-owned missile manufacturer?

Apollo Micro Systems Ltd. (IPO)

Jan 9, 2018

Should you subscribe to the IPO of Apollo Micro Systems Ltd?

Hindustan Aeronautics IPO: Yet Another Play on India's Defence Sector (IPO)

Mar 14, 2018

Should you apply for the IPO of state-run military aircraft maker Hindustan Aeronautics?

Bharat Dynamics IPO: Worth Betting on Defence Manufacturing? (IPO)

Mar 12, 2018

Should you apply for the IPO of Bharat Dynamics, India's first state-owned missile manufacturer?

More Views on News

Most Popular

My Top 7 Stocks to Buy Now(The 5 Minute Wrapup)

Nov 30, 2018

Of all the stocks that you could buy in this market, I've picked the seven best safe stocks that offer the ideal combination of safety and profit.

4 Rebound Stocks to Profit from the Current Small Cap Crash(Profit Hunter)

Dec 3, 2018

Indian small cap space is offering a discount season. Make sure you do not get too late to scoop up the bargains.

Reliance CPSE ETF (FFO3): Should You Invest?(Outside View)

Nov 29, 2018

Personalfn's analysis note on Reliance Mutual Fund Central Public Sector Enterprises Exchange Traded Fund (CPSE ETF). Should you subscribe?

Safety Beats Growth in 2018(Chart Of The Day)

Nov 30, 2018

With the markets turning up, these are my top 7 stock picks.

Looking For Higher Interest Rates on Bank FDs? Read This!(Outside View)

Dec 5, 2018

Credit disbursement to the productive sectors of the economy such as infrastructure, engineering, food processing, textiles, and chemicals, among others is rising.

More

Small Investments
BIG Returns

Zero To Millions Guide 2019
Get our special report, Zero To Millions
(2019 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS - CIPLA COMPARISON

COMPARE DR. DATSONS LABS WITH

MARKET STATS